Error title
Some error text about your books and stuff.
Close

Surrogate Markers to Assess Efficacy of Treatment in Chronic Liver Diseases Proceedings of the International Falk Workshop Held in Basel, Switzerland,

by J. Reichen

  • ISBN: 9780792387053
  • ISBN10: 0792387058

Surrogate Markers to Assess Efficacy of Treatment in Chronic Liver Diseases Proceedings of the International Falk Workshop Held in Basel, Switzerland,

by J. Reichen

  • List Price: $155.00
  • Binding: Hardcover
  • Publisher: Kluwer Academic Pub
  • Publish date: 06/01/1996
  • ISBN: 9780792387053
  • ISBN10: 0792387058
new Add to Cart $9.84
You save: 94%
Marketplace Item
Description: Introduction; R.E. Poupon. Section I: General Considerations on Surrogate Markers. 1. Surrogate Markers in AIDS Clinical Trials; J.-P. Aboulker. 2. Surrogate Markers and Prediction of Cardiovascular Disease; P.W.F. Wilson. 3. Requirements for Surrogate Markers as Seen by Regulatory Agencies; C. Peck. Section II: Scores and Quantitative Tests. 4. Quantitative Liver Function Tests; N. Tygstrup. 5. The Threshold Hypothesis of Sodium Retention in the Presence of Liver Disease Provides a Surrogate Marker for the Onset of Ascites; R.A. Branch. 6. Scores in Different Diseases. A Critical Review and Evaluation of Different Surrogate Markers for Assessing Treatments in Chronic Liver Disease; E. Christensen, M.R. Schunk. 7. Validation of Surrogate Markers for Death in Cirrhosis: an Example Using Decrease in Galactose Elimination Capacity; C. Merkel, et al. 8. Quantitative Liver Function Tests as Surrogate Markers for End Points in Controlled Clinical Trials; E. Lotterer, et al. Section III: Cirrhosis and Portal Hypertension. 9. The Child-Turcotte and Chilf-Pugh Classifications; N. McIntyre. 10. Portal Hypertension and Survival; J. Bosch, et al. 11. Impact of Ascites on Survival of Patients with Liver Cirrhosis; M. Bernardi, et al. Section IV: New and Old Markers. 12. Serum Markers for Liver Fibrosis - Current and Future Developments; D. Schppan, et al. 13. Surrogate Markers to Assess Efficiency of Treatment in Chronic Liver Diseases: New Biochemical Indices; G. Ramadori, F. Polzien. 14. Liver Biopsy as a Surrogate Marker in Chronic Liver Disease; B. Portmann. 15. Measurement of Quality of Life; A.J. Chwalow. 16. Surrogate Markers: Quality of Life in Liver Disease; H.U. Fisch, et al. Section V: Chronic Liver Disease. 17. Assessment of Treatment in Cholestasis; U. Beuers, G. Paumgartner. 18. Hepatic Uptake and Excretion of Bile Acids: Quantitative Tests of Liver Function in Chronic Cholestatic Liver Diseases; R.P. Jazrawi, et al. 19. Surrogate Markers to Assess Efficacy of Treatment in Chronic Liver Diseases: Viral Hepatitis; L. Pagliario, et al. 20. Surrogate Markers in Chronic Liver Diseases &e Essence from the Poster Session; J. Scholmerich. Concluding Remarks; J. Reichen. Index.
Expand description
Seller Condition Comments Price  
Seller: Ergodebooks
Location: Richmond, TX Ask seller a question
Condition: New
Buy with confidence. Excellent Customer Service & Return policy.Ships Fast. 24*7 Customer Service.
Price:
$9.84
Comments:
Buy with confidence. Excellent Customer Service & Return policy.Ships Fast. 24*7 Customer Service.
please wait
Please Wait

Notify Me When Available

Enter your email address below,
and we'll contact you when your school adds course materials for
.
Enter your email address below, and we'll contact you when is back in stock (ISBN: ).